Albaconazole for onychomycosis

A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis. Sigurgeirsson B, van Rossem K, Malahias S, Raterink K. J Am Acad Dermatol

Here is the original post:
Albaconazole for onychomycosis

This entry was posted in Podiatry Arena. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *